APA

Rocco V. P., Spinazze P. G., Kohn T. J., Honigschmidt N. A., Nelson D. L., Bradley Wainscott D., Ahmad L. J., Shaw J., Threlkeld P. G., Wong D. T. & Takeuchi K. (20041222). Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 4. : Bioorganic & medicinal chemistry letters.

Chicago

Rocco Vincent P, Spinazze Patrick G, Kohn Todd J, Honigschmidt Nicholas A, Nelson David L, Bradley Wainscott D, Ahmad Laura J, Shaw Janice, Threlkeld Penny G, Wong David T and Takeuchi Kumiko. 20041222. Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 4. : Bioorganic & medicinal chemistry letters.

Harvard

Rocco V. P., Spinazze P. G., Kohn T. J., Honigschmidt N. A., Nelson D. L., Bradley Wainscott D., Ahmad L. J., Shaw J., Threlkeld P. G., Wong D. T. and Takeuchi K. (20041222). Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 4. : Bioorganic & medicinal chemistry letters.

MLA

Rocco Vincent P, Spinazze Patrick G, Kohn Todd J, Honigschmidt Nicholas A, Nelson David L, Bradley Wainscott D, Ahmad Laura J, Shaw Janice, Threlkeld Penny G, Wong David T and Takeuchi Kumiko. Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 4. : Bioorganic & medicinal chemistry letters. 20041222.